Ranibizumab (Lucentis) pro terapii věkem podmíněné makulární degenerace
| Title in English | Ranibizumab (Lucentis) for treatment of age related macular degeneration |
|---|---|
| Authors | |
| Year of publication | 2008 |
| Type | Article in Proceedings |
| Conference | Praktické lékárenství (Astrakta II. kongresu praktického lékárenství) |
| MU Faculty or unit | |
| Citation | |
| Web | pořadatel |
| Field | ORL, ophthalmology, stomatology |
| Keywords | ranibizumab; age related macular degeneration; vascular endothelial growth factor; intraocular injection into vitreous humour |
| Description | Ranibizumab is a fragment of recombinant humanized monoclonar antibody against vascular growth factor. It is used for treatment of wet age related macular degeneration. |